| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |